We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$8.18B
AUM Growth
+$575M
Cap. Flow
+$287M
Cap. Flow %
3.5%
Top 10 Hldgs %
22.5%
Holding
126
New
11
Increased
85
Reduced
21
Closed
9

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$51.9M
2
CTLT
CATALENT, INC.
CTLT
+$51.2M
3
LNCE
Snyders-Lance, Inc.
LNCE
+$46M
4
HRL icon
Hormel Foods
HRL
+$40.1M
5
VRSK icon
Verisk Analytics
VRSK
+$36.9M

Top Sells

Rank Stock Value
1
APFH
AdvancePierre Foods Holdings
APFH
+$72.7M
2
MJN
Mead Johnson Nutrition Company
MJN
+$70.9M
3
CST
CST Brands, Inc.
CST
+$32.9M
4
RBC icon
RBC Bearings
RBC
+$29.7M
5
DCI icon
Donaldson
DCI
+$29.4M

Sector Composition

Rank Sector Weight
1 Healthcare 23.86%
2 Technology 17.97%
3 Industrials 16.69%
4 Financials 15.42%
5 Consumer Staples 13.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBH icon
51
Sally Beauty Holdings
SBH
$1.49B
$69.6M 0.85%
3,436,205
+82,495
+2% +$1.59M
SXI icon
52
Standex International
SXI
$3.31B
$69.1M 0.85%
762,277
+142,687
+23% +$13M
BGS icon
53
B&G Foods
BGS
$257M
$68.3M 0.83%
1,918,022
+382,079
+25% +$15.2M
PODD icon
54
Insulet
PODD
$9.15B
$67.4M 0.82%
1,314,405
+169,530
+15% +$7.36M
HSIC icon
55
Henry Schein
HSIC
$9.85B
$66.9M 0.82%
931,655
+81,714
+10% +$5.69M
NAVG
56
DELISTED
Navigators Group Inc
NAVG
$66.1M 0.81%
1,203,562
+133,922
+13% +$7.12M
FNGN
57
DELISTED
Financial Engines, Inc.
FNGN
$66M 0.81%
1,802,947
+65,577
+4% +$2.61M
GWW icon
58
W.W. Grainger
GWW
$60.3B
$65.7M 0.8%
364,100
-68,495
-16% -$12.9M
SRCL
59
DELISTED
Stericycle Inc
SRCL
$63.3M 0.77%
828,938
+16,623
+2% +$1.37M
ANSS
60
DELISTED
Ansys
ANSS
$62.6M 0.77%
514,530
-90,645
-15% -$10.7M
HELE icon
61
Helen of Troy
HELE
$624M
$62.2M 0.76%
661,300
+125,235
+23% +$11.7M
LDL
62
DELISTED
Lydall, Inc.
LDL
$61.9M 0.76%
1,197,526
+124,456
+12% +$6.41M
TRS icon
63
TriMas Corp
TRS
$1.38B
$60.6M 0.74%
2,908,719
+35,954
+1% +$776K
CBSH icon
64
Commerce Bancshares
CBSH
$8.35B
$59.6M 0.73%
1,626,692
+42,522
+3% +$1.52M
CMD
65
DELISTED
Cantel Medical Corporation
CMD
$59M 0.72%
757,382
+85,097
+13% +$6.39M
UMBF icon
66
UMB Financial
UMBF
$10.6B
$58.5M 0.72%
781,778
+16,298
+2% +$1.19M
CSII
67
DELISTED
Cardiovascular Systems, Inc.
CSII
$58.1M 0.71%
1,801,762
+59,477
+3% +$1.81M
TAP icon
68
Molson Coors Class B
TAP
$7.26B
$57.4M 0.7%
665,285
+6,275
+1% +$581K
CTLT
69
DELISTED
CATALENT, INC.
CTLT
$54.7M 0.67%
+1,558,010
New +$51.2M
CVBF icon
70
CVB Financial
CVBF
$3.95B
$53M 0.65%
2,362,507
+52,472
+2% +$1.12M
IOSP icon
71
Innospec
IOSP
$2.27B
$50.8M 0.62%
775,509
+11,519
+2% +$740K
CLB icon
72
Core Laboratories
CLB
$574M
$49.2M 0.6%
485,406
+6,636
+1% +$715K
EPAC icon
73
Enerpac Tool Group
EPAC
$1.8B
$46.4M 0.57%
1,884,345
+22,680
+1% +$582K
SAM icon
74
Boston Beer
SAM
$1.78B
$45.8M 0.56%
346,506
+1,671
+0.5% +$234K
FTNT icon
75
Fortinet
FTNT
$125B
$44.8M 0.55%
5,978,950
+264,550
+5% +$2.05M
1 2
3
4 5

Similar funds

NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $3.89B AUM
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $3.9B AUM
AC
Anther Capital Hong Kong $3.91B AUM

Champlain Investment Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Champlain Investment Partners held 126 positions worth $8.18B, up 7.6% from $7.61B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Champlain Investment Partners deployed $287M of net new capital in Q2 2017, opening 11 new positions and adding to 85 existing holdings. Its largest new stake was CATALENT, INC.: 1,558,010 shares worth $54.7M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $21.2M trimmed.

  • Champlain Investment Partners's largest Q2 2017 buy was CATALENT, INC.: 1,558,010 shares worth $54.7M.
  • Champlain Investment Partners added most to RB Global in Q2 2017, an estimated $51.9M increase.
  • Champlain Investment Partners's biggest Q2 2017 reduction was Dover, cutting an estimated $21.2M.
  • Champlain Investment Partners fully exited AdvancePierre Foods Holdings in Q2 2017, selling an estimated $72.7M.
  • Champlain Investment Partners's ten largest holdings make up 22% of its $8.18B portfolio in Q2 2017.
  • Champlain Investment Partners opened 11 new positions and closed 9 in Q2 2017.
  • Champlain Investment Partners's portfolio value rose 7.6% quarter-over-quarter to $8.18B.

Based on Champlain Investment Partners's 13F filing for Q2 2017, filed 11 Aug 2017.